MedPath

GENOSYL

These highlights do not include all the information needed to use GENOSYL safely and effectively. See full prescribing information for GENOSYL.GENOSYL (nitric oxide), for inhalation use Initial U.S. Approval: 1999

Approved
Approval ID

c9560c54-9e28-4039-a4e5-5000c41c6c85

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 19, 2023

Manufacturers
FDA

VERO BIOTECH, INC.

DUNS: 872672477

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

nitric oxide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72385-001
Application NumberNDA202860
Product Classification
M
Marketing Category
C73594
G
Generic Name
nitric oxide
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateDecember 19, 2023
FDA Product Classification

INGREDIENTS (1)

NITRIC OXIDEActive
Quantity: 0.98 mg in 1 L
Code: 31C4KY9ESH
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

GENOSYL - FDA Drug Approval Details